- 1. De Toni-Debre-Fanconi Syndrome
- [constellation of clinical and laboratory manifestations produced by generalized proximal tubular insufficiency in the presence of normal, or nearly normal, glomerular filtration. ( CSP )] (UMLS (NCI) C0015624) =Disease or Syndrome =cystine storage disease;
syndrome;
inborn biological transport disorder;
| - 17. Deterioration
- [Deterioration is a symptom or state of reduced quality or strength. (NCI) ( NCI )] (UMLS (NCI) C0868945) =Phenomenon or Process ;
|
- 2. DETACH RET PHOTOCOAG NOS
- [ ] (UMLS (ICD9CM) C0844604) Repair of retinal detachment with photocoagulation of unspecified type =Therapeutic or Preventive Procedure
| - 18. Deticene
- (UMLS (NCI) C0728896) =Organic Chemical; Pharmacologic Substance
|
- 3. DETACH RETINA LASER COAG
- [ ] (UMLS (ICD9CM) C0395569) =Therapeutic or Preventive Procedure
| - 19. Detox
- [A cancer vaccine adjuvant consisting of a combination of the active monophosphoryl lipid A component of lipopolysaccharide (LPS) isolated from the bacterium Salmonella minnesota combined with a residue of the cell wall of the bacterium Mycobacterium phlei. Detox is a non-specific immunostimulant that may enhance the host immune response to certain cancer vaccines. (NCI04) ( NCI )] (UMLS (NCI) C0674607) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 4. DETACH RETINA XENON COAG
- [ ] (UMLS (ICD9CM) C0395570) =Therapeutic or Preventive Procedure
| - 20. Detox PC
- [A detoxified, nonspecific immunostimulant consisting of a combination of the active monophosphoryl lipid A component of lipopolysaccharide (LPS) isolated from the bacterium Salmonella minnesota combined with a residue of the cell wall of the bacterium Mycobacterium phlei. Detox-PC differs from Detox adjuvant and Detox-B in that Detox-PC contains egg phosphatidylcholine and alpha-tocopherol. (NCI04) ( NCI )] (UMLS (NCI) C0393052) =Organic Chemical; Pharmacologic Substance ;
|
- 5. DETACH RETINA-CRYOTHERAP
- [ ] (UMLS (ICD9CM) C0176272) =Therapeutic or Preventive Procedure
| - 21. Detox-B Adjuvant
- [A cancer vaccine adjuvant that consists of an oil droplet emulsion of monophosphoryl lipid A and mycobacterial cell wall skeleton. Detox-B adjuvant is a non-specific immunostimulant that may enhance the host immune response to certain cancer vaccines. Detox-B differs from Detox adjuvant in that Detox-B contains lecithin. (NCI04) ( NCI )] (UMLS (NCI) C0935654) Detox-B SE Adjuvant;
Detox-B Stable Emulsion =Lipid; Pharmacologic Substance ;
|
- 6. DETACH RETINA-DIATHERMY
- [ ] (UMLS (ICD9CM) C0176271) =Therapeutic or Preventive Procedure
| - 22. Detox-B Adjuvant/Keyhole Limpet Hemocyanin/Sialyl Tn Antigen
- (UMLS (NCI) C0935656) =Therapeutic or Preventive Procedure
|
- 7. detached
- [Detach this branch from the other branches so it will not be resynchronized with the other branches. ( HL7V3.0 )] (UMLS (HL7) C1561504) =Idea or Concept =ActRelationshipJoin;
| - 23. Detox-B Adjuvant/RAS Peptide Cancer Vaccine
- (UMLS (NCI) C0935822) =Therapeutic or Preventive Procedure
|
- 8. Detached retina
- [separation of the inner layers of the retina from the pigment epithelium.(CSP)] (UMLS (ICPC) C0035305) (Detached retina; ERRETINAREN DESPRENDIMENTUA; Nethindelosning; Netvlies loslating; VERKKOKALVON IRTOAMINEN; Decollement de la retine; Netzhautabloesung; hafradat rishtit; retinalevalas; Distacco di retina; NETTHINNEAVLOSNING; Descolamento da retina; Desprendimiento de retina; NATHINNEAVLOSNING) =Disease or Syndrome ;
=EYE; ANDRE NETTHINNESYKDOMMER - h35.0; Diagnosis/Diseases Component; | - 24. Detox-B Adjuvant/Verteporfin
- (UMLS (NCI) C0935744) =Therapeutic or Preventive Procedure
|
- 9. Detachment of vitreous
- [Detachment of the corpus vitreum (VITREOUS BODY) from its normal attachments, especially the retina, due to shrinkage from degenerative or inflammatory conditions, trauma, myopia, or senility. ( MSH )] (UMLS (NCI) C0042907) =Disease or Syndrome ;
=Disorder of eye, unspecified;
| - 25. detoxication
- [ ] (UMLS (CSP) C0598281) =Organism Function
|
- 10. DETACHMNT W DEFECT NOS
- [ ] (UMLS (ICD9CM) C0154808) =Disease or Syndrome
| - 26. detoxification
- [reduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action; includes those metabolic transformations that make the substance more soluble for faster renal excretion. ( CSP )] (UMLS (CSP) C0025516) =Organism Function ;
=toxin metabolism;
|
- 11. detail
- [Respond with exceptions, completion, modifications and include more detail information (if applicable) ( HL7V3.0 )] (UMLS (HL7) C1561567) =Functional Concept =ResponseLevel;
| - 27. Detoxpc/Interleukin-2/RAS Peptide Cancer Vaccine/Sargramostim
- (UMLS (NCI) C1134596) =Therapeutic or Preventive Procedure ;
|
- 12. Detail financial transactions
- (UMLS (HL7) C1548020) =Idea or Concept =Message type;
| - 28. Detoxpc/Lung Tumor Associated Antigen
- (UMLS (NCI) C0796688) =Therapeutic or Preventive Procedure ;
|
- 13. Detectable Residual Disease
- [remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy. ( CSP )] (UMLS (NCI) C0242596) =Neoplastic Process ;
=CA;
neoplastic process | - 29. Detrusor Muscle of the Bladder
- [The detrusor muscle of the bladder, forming the muscular wall of the bladder, consisting of the inner longitudinal; middle circular; and outer longitudinal layers. ( NCI )] (UMLS (NCI) C0225358) =Tissue
|
- 14. detected issue
- [An observation identifying a potential adverse outcome as a result of an Act or combination of Acts. Examples: Detection of a drug-drug interaction; Identification of a late-submission for an invoice; Requesting discharge for a patient who does not meet hospital-defined discharge criteria. Discussion: This class is commonly used for identifying 'business rule' or 'process' problems that may result in a refusal to carry out a particular request. In some circumstances it may be possible to 'bypass' a problem by modifying the request to acknowledge the issue and/or by providing some form of mitigation. Constraints: the Act or Acts that may cause the the adverse outcome are the target of a subject ActRelationship. The subbtypes of this concept indicate the type of problem being detected (e.g. drug-drug interaction) while the Observation.value is used to repesent a specific problem code (e.g. specific drug-drug interaction id). ( HL7V3.0 )] (UMLS (HL7) C1553443) =Idea or Concept =observation;
| - 30. Detrusor sphincter dyssynergia
- [ ] (UMLS (ICD9CM) C0341747) =Disease or Syndrome
|
- 15. Detector
- [A mechanical, electrical, or chemical device with sensor properties, that automatically identifies and records or registers a stimulus, such as change in pressure or temperature or content, movement, an electrical signal, radiation from a radioactive material or presence of subatomic particles, etc. ( NCI )] (UMLS (NCI) C0180392) =Medical Device
| - 31. Detubation
- [The removal of a previously inserted tube from a hollow organ or passageway, often from the airway. ( NCI )] (UMLS (NCI) C0553891) =Therapeutic or Preventive Procedure ;
|
- 16. detergent
- [purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. ( CSP )] (UMLS (CSP) C0011740) =Chemical Viewed Functionally =reagent/indicator;
| |
home
